# CRDMO

About 9 search results

Sort by Date

WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy

C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework

WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market

WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility

Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day

PharmaBlock's First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational

WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year

About Storm Media

The Storm Media (world.storm.mg) is dedicated to bringing Taiwan's voice to the world. We deliver timely, balanced, and internationally oriented reporting and in-depth analysis on key issues including democratic politics, cross-strait relations, geopolitics, Indo-Pacific strategy, technology industry, and economic trends — helping global readers gain a deeper understanding of Taiwan and the Asia-Pacific region.

The Storm Media (Chinese)

The Storm Media Japan

The Journalist

1% STYLE

Neihu District, Ruiguang Road, Lane 513, No. 37, 4F. Taipei, 114.

Stay True・Look Beyond

Version: 20260721-092054